TDC Teradata Corp. gains 18% May 4, 2021

Teradata Corporation, together with its subsidiaries, provides multi-cloud enterprise data warehouse platform. Its solutions and services comprise software, hardware, and related business consulting and support services to deliver analytics in company's analytical ecosystem. The company operates through three segments: North America and Latin America region; Europe, Middle East and Africa region; and Asia Pacific and Japan region. It offers Teradata Vantage, a data warehouse and analytics platform. The company's business consulting services include various offerings, such as support for organizations to establish a data and analytic vision, and identify and operationalize analytical opportunities, as well as enable an analytical ecosystem architecture. It serves various industries comprising financial, government, healthcare, manufacturing, retail, telecommunications, and travel/transportation. The company primarily sells and markets its solutions and services through a direct sales force. Teradata Corporation was incorporated in 1979 and is headquartered in San Diego, California.http://www.priceseries.com/trade/TDC-Teradata-Corp-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2021042120210504.html

STX Seagate Technology PLC gains 18% May 4, 2021

Seagate Technology plc provides data storage technology and solutions in Singapore, the United States, the Netherlands, and internationally. The company offers hard disk and solid state drives, including serial advanced technology attachment, serial attached SCSI, and non-volatile memory express products; solid state hybrid drives; and storage subsystems. Its products are used in enterprise servers and storage systems; and edge compute and non-compute applications. The company also provides enterprise data solutions portfolio comprising storage subsystems for enterprises, cloud service providers, and scale-out storage servers and original equipment manufacturers (OEMs). In addition, it offers external storage solutions under the Seagate Backup Plus and Expansion product lines, as well as under the LaCie and Maxtor brands in capacities up to 168TB. The company sells its products primarily to OEMs, distributors, and retailers. Seagate Technology plc was founded in 1978 and is based in Dublin, Ireland.http://www.priceseries.com/trade/STX-Seagate-Technology-PLC-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2021033020210504.html

STAA STAAR Surgical Company gains 34% May 4, 2021

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.http://www.priceseries.com/trade/STAA-STAAR-Surgical-Company-stock-gains-34-percent-a-Trade-Record-by-priceSeries-2021032520210504.html

RH Restoration Hardware Holdings Inc. gains 26% May 4, 2021

RH, together with its subsidiaries, operates as a retailer in the home furnishings. It offers products in various categories, including furniture, lighting, textiles, bathware, dcor, outdoor and garden, and child and teen furnishings. The company provides its products through its retail galleries; and Source Books, a series of catalogs, as well as online through rh.com, restorationhardware.com, rhbabyandchild.com, rhteen.com, and rhmodern.com, as well as waterworks.com. As of May 2, 2020, it operated a total of 69 RH Galleries and 38 RH outlet stores in 31 states in the District of Columbia and Canada, as well as 15 Waterworks showrooms throughout the United States and the United Kingdom. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was founded in 1979 and is headquartered in Corte Madera, California.http://www.priceseries.com/trade/RH-Restoration-Hardware-Holdings-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2021032520210504.html

ISRG Intuitive Surgical, Inc. gains 15% May 4, 2021

Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.http://www.priceseries.com/trade/ISRG-Intuitive-Surgical-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2021033020210504.html

INVE Identiv, Inc. gains 27% May 4, 2021

Identiv, Inc. operates as a security technology company that secures and manages access to physical places, things, and information worldwide. It operates through four segments: Premises (PACS), Identity, Credentials, and All Other. The PACS segment offers modular Hirsch MX controllers that allow customers to start with a small system and expand over time; Hirsch Velocity software platform for centralized management of access and security operations across an organization; Federal Identity, Credential and Access Management architecture, an access control system; and TouchSecure door readers that provide various features to support security standards. The Identity segment provides smart card readers, which include various contact, contactless, portable, and mobile smart card readers, as well as tokens and terminals to enable logical access, and security and identification applications, such as national ID, payment, e-health, and e-government. It also offers access cards and other devices related to its reader products. The Credentials segment provides NFC and radio frequency identification products, including inlays and inlay-based, and other cards; and labels, tags, and stickers, as well as other radio frequency and integrated circuits components for use in various applications, such as virtual reality, games, loyalty cards, mobile payment systems, transit and event ticketing, and brand authenticity from pharmaceuticals to consumer goods, hospital resource management, cold-chain management, and others. The All Other segment offers chip drives and digital media readers. Identiv, Inc. markets and sells its products through original equipment manufacturers, dealers, systems integrators, value added resellers, resellers, and Internet, as well as directly to end users. The company was formerly known as Identive Group, Inc. and changed its name to Identiv, Inc. in May 2014. Identiv, Inc. was founded in 1990 and is headquartered in Fremont, California.http://www.priceseries.com/trade/INVE-Identiv-Inc-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2021041220210504.html

IDXG Interpace Diagnostics Group, Inc. gains 29% May 3, 2021

PDI, Inc. provides outsourced commercial services to pharmaceutical, biotechnology, diagnostics, and healthcare companies in the United States. It operates in two segments, Commercial Services and Interpace Diagnostics. The Commercial Services segment offers outsourced sales teams that target healthcare providers, providing a range of complementary sales support services designed to achieve its customers' strategic and financial product objectives. This segment offers a range of personal and non-personal promotional options for the commercialization of their products throughout the product lifecycles, from development through maturity. It also provides other promotional services, including clinical educator, teledetailing, and full product commercialization services. This segment's services include product distribution, personal and non-personal product detailing, full supply chain management, operations, sales, marketing, compliance, and regulatory/medical management. The Interpace Diagnostics segment focuses on developing and commercializing molecular diagnostic tests for physicians and patients with diagnostic options for detecting genetic and other molecular alterations associated with gastrointestinal and endocrine cancers. This segment offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; and ThyGenX, a next-generation sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules. It also has three diagnostic tests in late stage development that are designed to detect genetic alterations that are associated with gastrointestinal cancers; and one diagnostic test in late stage development that is designed to detect genetic alterations that are associated with endocrine cancers. PDI, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.http://www.priceseries.com/trade/IDXG-Interpace-Diagnostics-Group-Inc-stock-gains-29-percent-a-Trade-Record-by-priceSeries-2021040120210503.html

CTMX CytomX Therapeutics, Inc. gains 16% May 4, 2021

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops a novel class of investigational antibody therapeutics based on its Probody technology platform for the treatment of cancer. Its product candidates in clinical stage include CX-072, a Probody therapeutic targeting programmed cell death ligand 1 immuno-oncology target; CX-2009, a Probody drug conjugate (PDC) against CD166 novel drug target; BMS-986249, a CTLA-4 Probody therapeutic drug for the treatment of metastatic melanoma; CX-2029, a PDC targeting CD71 for solid tumors; and BMS-986288, an anti-CTLA-4 Probody drug for solid tumors. The company has strategic collaborations with AbbVie Ireland Unlimited Company, Amgen, Inc., Bristol-Myers Squibb Company, ImmunoGen, Inc., Pfizer Inc., and Astellas Pharma Inc. to develop Probody therapeutics. CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.http://www.priceseries.com/trade/CTMX-CytomX-Therapeutics-Inc-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2021041920210504.html

CLDX Celldex Therapeutics, Inc. gains 30% May 4, 2021

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of immunotherapies and other cancer-targeting biologics. It develops CDX-1140, an agonist human monoclonal antibody, which is being studied as a single-agent and in combination with CDX-301 in a Phase I dose-escalation study in metastatic solid tumors and B cell lymphomas; CDX-3379, a monoclonal antibody designed to block the activity of ErbB3 that is in an early Phase II study in advanced head and neck squamous cell cancer in combination with Erbitux; CDX-0159, a Phase I monoclonal antibody that binds the KIT receptor and inhibits its activity; and CDX-527, a bispecific antibody that uses anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway. The company also holds exclusive rights to CDX-301 and CD40 ligand, which are immune modulating molecules that increase the numbers and activity of immune cells that control immune responses. Celldex Therapeutics, Inc. has research collaboration and license agreements with University of Southampton; Amgen Inc.; Yale University; and MedImmune, LLC. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.http://www.priceseries.com/trade/CLDX-Celldex-Therapeutics-Inc-stock-gains-30-percent-a-Trade-Record-by-priceSeries-2021041420210504.html

CCI Crown Castle Intl. Corp. gains 19% May 4, 2021

Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States, Germany, the United Kingdom, and internationally. It focuses on diseases affecting the back of the eye or retina. The company offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and could lead to severe vision loss and blindness. Its ILUVIEN is inserted in the back of the patient's eye in a non-surgical procedure, which allows for a self-sealing wound by delivering a continuous microdose of the non-proprietary corticosteroid fluocinolone acetonide in the eye. The company has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of proprietary insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. It sells its products through direct sales and distributors. The company serves physician offices, pharmacies, and hospitals. Alimera Sciences, Inc. was founded in 2003 and is headquartered in Alpharetta, Georgia.http://www.priceseries.com/trade/CCI-Crown-Castle-Intl-Corp-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2021031120210504.html